1105 related articles for article (PubMed ID: 19771768)
21. Primary cutaneous B-cell lymphomas. Current concepts. I.
Santucci M; Pimpinelli N
Haematologica; 2004 Nov; 89(11):1360-71. PubMed ID: 15531459
[TBL] [Abstract][Full Text] [Related]
22. Results of radiotherapy in 153 primary cutaneous B-Cell lymphomas classified according to the WHO-EORTC classification.
Senff NJ; Hoefnagel JJ; Neelis KJ; Vermeer MH; Noordijk EM; Willemze R;
Arch Dermatol; 2007 Dec; 143(12):1520-6. PubMed ID: 18087001
[TBL] [Abstract][Full Text] [Related]
23. Recurrent localized primary cutaneous marginal-zone B cell lymphoma.
Marmon S; Chu J; Patel R; Meehan S; Pomeranz MK
Dermatol Online J; 2011 Oct; 17(10):27. PubMed ID: 22031653
[TBL] [Abstract][Full Text] [Related]
24. Primary cutaneous B-cell lymphoma treated with radiotherapy: a comparison of the European Organization for Research and Treatment of Cancer and the WHO classification systems.
Smith BD; Glusac EJ; McNiff JM; Smith GL; Heald PW; Cooper DL; Wilson LD
J Clin Oncol; 2004 Feb; 22(4):634-9. PubMed ID: 14966086
[TBL] [Abstract][Full Text] [Related]
25. A nodular syphilid presenting as a pseudolymphoma: mimicking a cutaneous marginal zone B-cell lymphoma.
Moon HS; Park K; Lee JH; Son SJ
Am J Dermatopathol; 2009 Dec; 31(8):846-8. PubMed ID: 19786852
[TBL] [Abstract][Full Text] [Related]
26. Controversies and considerations in the diagnosis of primary cutaneous CD4⁺ small/medium T-cell lymphoma.
Lan TT; Brown NA; Hristov AC
Arch Pathol Lab Med; 2014 Oct; 138(10):1307-18. PubMed ID: 25268194
[TBL] [Abstract][Full Text] [Related]
27. Primary cutaneous marginal zone B-cell lymphomas: are they different from other extranodal marginal zone B-cell lymphomas?
Ferenczi K
J Cutan Pathol; 2009 Jun; 36(6):715-7. PubMed ID: 19515055
[No Abstract] [Full Text] [Related]
28. The value of molecular diagnostics in primary cutaneous B-cell lymphomas in the context of clinical findings, histology, and immunohistochemistry.
Felcht M; Booken N; Stroebel P; Goerdt S; Klemke CD
J Am Acad Dermatol; 2011 Jan; 64(1):135-43, 143.e1-4. PubMed ID: 21167409
[TBL] [Abstract][Full Text] [Related]
29. Cutaneous MALT-lymphoma: from cutaneous immunocytoma and pseudolymphoma to the current (and future) conceptions.
Fernandez-Flores A
Rom J Morphol Embryol; 2013; 54(1):7-12. PubMed ID: 23529303
[TBL] [Abstract][Full Text] [Related]
30. [New aspects in the classification of cutaneous lymphomas].
Erós N; Károlyi Z; Kovács A
Orv Hetil; 2001 Feb; 142(8):393-8. PubMed ID: 11263077
[TBL] [Abstract][Full Text] [Related]
31. B-cell cutaneous lymphoid hyperplasia representing progressive transformation of germinal center: a report of 2 cases.
Kojima M; Sakurai S; Shimizu K; Itoh H
Int J Surg Pathol; 2010 Oct; 18(5):429-32. PubMed ID: 18815203
[TBL] [Abstract][Full Text] [Related]
32. Transformation of vulvar pseudolymphoma (lymphoma-like lesion) into a marginal zone B-cell lymphoma of labium majus.
Martorell M; Gaona Morales JJ; Garcia JA; Manuel Gutierrez Herrera J; Grau FG; Calabuig C; Vallés AP
J Obstet Gynaecol Res; 2008 Aug; 34(4 Pt 2):699-705. PubMed ID: 18840185
[TBL] [Abstract][Full Text] [Related]
33. The spectrum of cutaneous lymphomas in patients less than 20 years of age.
Fink-Puches R; Chott A; Ardigó M; Simonitsch I; Ferrara G; Kerl H; Cerroni L
Pediatr Dermatol; 2004; 21(5):525-33. PubMed ID: 15461755
[TBL] [Abstract][Full Text] [Related]
34. Letter: Primary cutaneous marginal zone B cell lymphoma of the face: a challenging diagnosis.
Oliveira A; Caetano M; Alves R; Lima M; Selores M
Dermatol Online J; 2012 Feb; 18(2):12. PubMed ID: 22398233
[TBL] [Abstract][Full Text] [Related]
35. Marginal zone lymphomas.
Zucca E; Bertoni F; Stathis A; Cavalli F
Hematol Oncol Clin North Am; 2008 Oct; 22(5):883-901, viii. PubMed ID: 18954742
[TBL] [Abstract][Full Text] [Related]
36. Diagnostic principles and new developments in primary cutaneous B-cell lymphomas.
Kerl H; Kodama K; Cerroni L
J Dermatol Sci; 2004 May; 34(3):167-75. PubMed ID: 15113586
[TBL] [Abstract][Full Text] [Related]
37. Results of bone marrow examination in 275 patients with histological features that suggest an indolent type of cutaneous B-cell lymphoma.
Senff NJ; Kluin-Nelemans HC; Willemze R
Br J Haematol; 2008 Jul; 142(1):52-6. PubMed ID: 18422781
[TBL] [Abstract][Full Text] [Related]
38. Low-dose palliative radiotherapy for cutaneous B- and T-cell lymphomas.
Neelis KJ; Schimmel EC; Vermeer MH; Senff NJ; Willemze R; Noordijk EM
Int J Radiat Oncol Biol Phys; 2009 May; 74(1):154-8. PubMed ID: 18834672
[TBL] [Abstract][Full Text] [Related]
39. Partial nodal involvement by marginal zone lymphoma. Use of IGK gene rearrangement analysis in diagnostic work-up.
Gazzola A; Sabattini E; Mannu C; Bacci F; Sagramoso Sacchetti CA; Artioli P; Chilli L; Da Pozzo G; Piccioli M; Falini B; Pileri SA; Piccaluga PP
Pathologica; 2011 Feb; 103(1):14-8. PubMed ID: 21837920
[TBL] [Abstract][Full Text] [Related]
40. Marginal zone B-cell lymphoma of the uterus: a case report and review of the literature.
Hamadani M; Kharfan-Dabaja M; Kamble R; Kern W; Ozer H
J Okla State Med Assoc; 2006 Apr; 99(4):154-6. PubMed ID: 16703935
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
